参考文献/References:
[1]Rani KU,Holi MS. Automatic detection of neurological disordered voices using mel cepstral coefficients and neural networks[C]. 2013 IEEE Point-of-Care Healthcare Technologies (PHT),IEEE,2013:76-79.
[2]Bonneh YS,Levanon Y,Dean-Pardo O,et al. Abnormal speech spectrum and increased pitch variability in young autistic children[J].?Front Hum Neurosci,2011,4:237.
[3]Orlikoff RF,Baken RJ. Fundamental frequency modulation of the human voice by the heartbeat:preliminary results and possible mechanisms[J].?J Acoust Soc Am,1989,85(2):888-893.
[4]Libby P. The changing landscape of atherosclerosis[J]. Nature,2021,592(7855): 524-533.
[5]Yang X,Li J,Hu D,et al. Predicting the 10-Year risks of atherosclerotic cardiovascular disease in Chinese population:the China-PAR project (prediction for ASCVD risk in China)[J]. Circulation,2016,134(19):1430-1440.
[6]Lin S,Li Z,Fu B,et al. Feasibility of using deep learning to detect coronary artery disease based on facial photo[J].Eur Heart J,2020,41(46):4400-4411.
[7]Levanon Y,Lossos-Shifrin L. Method and system for diagnosing pathological phenomenon using a voice signall:U.S. Patent 7,398,213[P]. 2008-7-8.
[8]Maor E,Sara JD,Orbelo DM,et al. Voice signal characteristics are independently associated with coronary artery disease[J].?Mayo Clin Proc,2018,93(7):840-847.
[9]Pareek V,Sharma RK. Coronary heart disease detection from voice analysis[C]. 2016 IEEE Students’ Conference on Electrical,Electronics and Computer Science (SCEECS),IEEE,2016:1-6.
[10]Abraham WT,Stevenson LW,Bourge RC,et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy:complete follow-up results from the CHAMPION randomised trial[J].?Lancet,2016,387(10017):453-461.
[11]Lindenfeld J,Zile MR,Desai AS,et al. Haemodynamic-guided management of heart failure (GUIDE-HF):a randomised controlled trial[J]. Lancet,2021,398(10304):991-1001.
[12]Lala A,Barghash MH,Giustino G,et al. Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions[J].?ESC Heart Fail,2021,8(2):1047-1054.
[13]Boehmer JP,Hariharan R,Devecchi FG,et al. A multisensor algorithm predicts heart failure events in patients with implanted devices:results from the MultiSENSE study[J]. JACC Heart Fail,2017,5(3):216-225.
[14]Maor E,Perry D,Mevorach D,et al. Vocal biomarker is associated with hospitalization and mortality among heart failure patients[J].?J Am Heart Assoc,2020,9(7):e013359.
[15]Murton OM,Hillman RE,Mehta DD,et al. Acoustic speech analysis of patients with decompensated heart failure:a pilot study[J].?J Acoust Soc Am,2017,142(4):EL401.
[16]Reddy MK,Helkkula P,Keerthana YM,et al. The automatic detection of heart failure using speech signals[J]. Computer Speech & Language,2021,69(3):101205.
[17]Amir O,Anker SD,Gork I,et al. Feasibility of remote speech analysis in evaluation of dynamic fluid overload in heart failure patients undergoing haemodialysis treatment[J].ESC Heart Fail,2021,8(4):2467-2472.
[18]Amir O,Abraham WT,Azzam ZS,et al. Remote speech analysis in the evaluation of hospitalized patients with acute decompensated heart?failure[J].?JACC Heart Fail,2022,10(1):41-49.
[19]Sch?bi D,Zhang YP,Kehl J,et al. Evaluation of speech and pause alterations in patients with acute and chronic heart failure[J].?J Am Heart Assoc,2022,11(21):e027023.
[20]Sara JDS,Maor E,Borlaug B,et al. Non-invasive vocal biomarker is associated with pulmonary hypertension[J].?PLoS One,2020,15(4):e0231441.
[21]Ank??han H. Blood pressure prediction from speech recordings[J]. Biomed Signal Process Control,2020,58:101842.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(6):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(6):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]